Home
Home Page
Recent Posts
Top Active Boards
Popular Posts
Biotech Tweets
Market Tweets
Energy Industry Tweets
Official IV Sponsor Page
My Content
My Boards
My Feed
My Library
My Links
Boards Search
Groups Directory
My Network
My Favorite Posters
My Private Message Groups
My Blocked Sender List
Member Directory
Account
Email & Password
Subscription/Membership
All Account Details
My Profile
My Device Info
Sign Up
Settings
My Site Settings
My Notification Settings
BOARDS
Sign In for Filters
|
BOARDS
Become a Member
|
Sign In
Advertise With Us
Board Stats
:
509 members / 2515 guests []
TCRT-PGEN Fundamental & Technical Discussion Board
Board
Links
(more...)
XON
ZIOP
@intrexon Twitter Link
Nature Medicine (Dr Steven Rosenberg) - Prospects for gene-engineered T cell immunotherapy for solid cancers
RJ Kirk SynBio Keynote
RJ Kirk interview
ZIOP CEO interview 15-30 IL-12 opportunities
Energy Countdown
CRMD
@ThomasUBarton1 Twitter Feed
BSGM & Electorphysiology Sector Board (come join)
@ziopharm Twitter Feed
Rosenberg Demystifying Medicine 2019 - Immunotherapy of Cancer
Dr. Rosenberg at AARC - Tcell Therapy Targeting Unique Mutations
Ziopharm/NCI TCR-T cell trial at the NCI has been initiated
2019 Edogawa NICHE Prize award ceremony - interaction with Dr. Steven A. Rosenberg (Oct. 22, 2019)
Changing Investing Landscape-ARK, Reddit, BTC, etc Message board
dividend champions
Cooper Presents (with Aldevron)
TCRT SEC filings
This is a semi-private group. You are free to browse messages, but you must be a member of this group to post messages.
Join This Group
Group: TCRT-PGEN Fundamental & Technical Discussion Board / Message Board
BOARD
Loading...
Written By
On Topic Only
--
All Messages
Hide Replies
Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
Go to Msg #
MSG #
SUBJECT
TYPE
AUTHOR
SENTIMENT
RECS
DATE POSTED
27737
Scaling Non-viral Cell Therapy Approaches For Solid Tumor Treatments
GN
Frank303
0
5/21/2022 9:02:54 PM
27736
Mirati Therapeutics Submits Marketing Authorization Application to the European Medicines Agency for Investigational Adagrasib as a Treatment for Previously-Treated KRASG12C-mutated Non-Small Cell Lung Cancer
GN
Frank303
0
5/21/2022 9:01:20 PM
27735
Re: Efficacy, safety, durability, AFFORDABILITY.
GN
Bohsie
0
5/20/2022 4:46:11 PM
27734
Inceptor Bio Snags $37M for Three-Pronged Immuno-Oncology Platforms
GN
Frank303
0
5/20/2022 1:54:14 PM
27733
Re: The scan on patient 1 has likely occurred. I would love to have a little information on the scan
GN
Bronxboy50
3
5/20/2022 11:34:48 AM
27732
The scan on patient 1 has likely occurred. I would love to have a little information on the scan
GN
kcchris
16
5/20/2022 9:09:17 AM
27731
NCI SAR
GN
jeikar
5
5/19/2022 8:26:26 PM
27730
Re: Short interest in the XBI @ 107%
GN
Jerseybill
6
5/19/2022 7:57:19 PM
27729
Re: Short interest in the XBI @ 107%
GN
clsm
2
5/19/2022 7:22:44 PM
27727
Re: Short interest in the XBI @ 107%
GN
dachmeister4u
31
5/19/2022 6:39:49 PM
Go to Msg #
About Us
•
Contact Us
•
Follow Us on Twitter
•
Members Directory
•
Help Center
•
Advertise
•
Official IV Sponsor Page
Become a Patron
© 2003-2022 Investorvillage.com. All rights reserved.
User Agreement
Financial Market Data provided by
.
Loading...